A new medical study published in the international academic journal Nature says that expanding or introducing vaccination programs against pneumococcus and rotavirus that can cause respiratory diseases and diarrhea is expected to reduce the use of antibiotics by children in low- and middle-income countries. This finding supports the priority given to vaccination in childhood in the global fight against drug resistance.
Corresponding author of the research paper, Joseph Lewnard of the University of California, Berkeley, and colleagues analyzed data from a large household survey conducted in low- and middle-income countries with the most significant drug resistance problems to evaluate pneumococcal and rotavirus vaccines for 5 years old The effects of antibiotic use in children below.
They found that 24.8% of respiratory infections treated with antibiotics and 21.6% of diarrhea infections are caused by pathogens that are sensitive to these vaccines. The rates of respiratory infections and diarrhea infections treated with antibiotics were reduced by 8.7% and 8.1%, respectively.
The author team estimates that among children in low- and middle-income countries, the current pneumococcal and rotavirus vaccination programs prevent approximately 23.8 million episodes of respiratory infections treated with antibiotics and 13.6 million episodes of diarrhea treated with antibiotics. If the coverage of vaccination is expanded in countries that have already used these vaccines, and vaccination of children is introduced in unused countries, it is possible to prevent an additional 40 million outbreaks of antibiotic-treated diseases.